Skip to main content

Currently Skimming:

Appendix C: Participant Biographies
Pages 109-128

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 109...
... He then spent 2 years doing postdoctoral research at The Johns Hopkins University in one of the leading laboratories involved in beta-lactam synthesis before joining the Intramural Research Laboratories of the National Institute of Allergy and Infectious Diseases in Hamilton, Montana, to study bacterial pathogens. After studying the pathogenesis of Chlamydia trachomatis, the leading cause of blindness in the developing world, he was given the opportunity in 1993 to start his own laboratory on 109
From page 110...
... She serves on numerous board and advisory groups such as the Scientific Advisory Committee on Stewardship for Research on Infectious Diseases of Poverty at WHO's Program for Research and Training in Tropical Diseases, the NIH Council of Councils, the board and executive committee of the Hamner Institute for Health Sciences, the board of the Health Effects Institute and the James B
From page 111...
... The partnership now involves over 20 partners, including WHO and CDC. She is the former Vice President of Infectious Diseases Drug Discovery and Clinical Development of Eli Lilly where she led the program of a hepatitis C protease inhibitor from the discovery phase to clinical candidate.
From page 112...
... For nine years she was chairman of the Public and Scientific Affairs Board of the American Society for Microbiology; has served as an advisor on infectious diseases and indirect costs of research to the White House Office of Science and Technology Policy, and has been an invited participant in numerous congressional hearings and briefings related to infectious diseases, antimicrobial resistance, and biomedical research. She has served two terms on the LCME, the accrediting body for U.S.
From page 113...
... Jason E Farley, Ph.D., M.P.H., CRNP, is an assistant professor at The Johns Hopkins University School of Nursing and a nurse practitioner in the Division of Infectious Diseases within The Johns Hopkins AIDS Service.
From page 114...
... Currently, she is member of the board of directors of the Health Research Alliance (an alliance of nongovernmental research funders) ; the IOM's Forum on Drug Discovery, Development and Translation; and the Sickle Cell Disease Advisory Committee at the
From page 115...
... in a high HIV prevalence setting, to create a community-based treatment program for MDR TB in HIV coinfected patients, and to develop a comprehensive airborne infection control program in a rural district hospital. Additionally, Dr.
From page 116...
... Stephen Lawn, M.D., is an associate professor of infectious diseases at the University of Cape Town, South Africa, and a reader in infectious diseases and tropical medicine at the London School of Hygiene and Tropical Medicine. He trained in infectious diseases in London and has also worked in Ghana, west Africa, and at CDC in the United States.
From page 117...
... , and non-governmental institutions. He was also Regional Health Sector Manager for RTI International, overseeing its health program operating in the Southern African Development Community (SADC)
From page 118...
... She completed a postdoctoral fellowship at the Pennsylvania State University, and worked at SmithKline and French Research and Development in King of Prussia, Pennsylvania, before returning to South Africa in 1989 to establish a research unit at the South African Institute for Medical Research in Johannesburg. Currently, she is director of the MRC/National Health Laboratory Service (NHLS)
From page 119...
... He is a physician executive who leverages his experience as a pediatrician, medical epidemiologist, and informatician to deliver strategic, operational, and scientific services to domestic and international clients in the health care and health information technology arenas. Recent projects include the development of a public−private partnership to build laboratory capacity for MDR TB across diverse international settings, which he is currently leading; development of governance structures for the National Biosurveillance System for Human Health; development of a multi-institutional collaboration
From page 120...
... Shreemanta K Parida, M.D., Ph.D., is a physician scientist from India working in the field of infectious diseases, with a particular focus on
From page 121...
... His research interests are in the fields of indoor air quality, building-related illnesses, and infection control.
From page 122...
... He has also been an invited copresenter in professional development programs, focusing on indoor air quality and occupational safety influences, including energy management and efficiency strategies. Over the past 8 years, he has worked with the MRC, CDC, and the Harvard School of Public Health on investigations into the efficacy of electro/mechanical building service systems for the protection of health care workers against airborne infectious diseases such as TB.
From page 123...
... He came to the University of KwaZulu-Natal in 1993 and has served as a professor, head of the medical microbiology department, and dean. He is also director of the MRC's genital ulcer disease research unit at the university.
From page 124...
... She is responsible for management of data processing for information on mortality and causes of death from civil registration systems, and for the production of statistical reports on mortality and causes of death and recorded live births. Martie van der Walt, MScAgric, M.B.A., Ph.D., is interim director for the TB Epidemiology and Intervention Research Unit and joined TB research at the MRC in 1998.
From page 125...
... in biotechnology from the University of Pretoria. Paul van Helden, Ph.D., obtained his doctorate in biochemistry in 1978 and has served on the Faculty of Health Sciences at Stellenbosch University, Cape Town, since January 1979.
From page 126...
... Since 2006 she has been employed by the International Center for AIDS Care and Treatment Programs (ICAP) , under Columbia University, as a technical advisor for TB/HIV integration, supporting selected districts in the Eastern Cape, KwaZulu-Natal, Free State, and Northern Cape Provinces to improve TB/HIV collaborative activities.
From page 127...
... mycobacterial epigenetics. Robin Wood, M.D., is director of the Desmond Tutu HIV Research Centre and Professor of Medicine at the University of Cape Town, visiting scientist at Harvard University Medical School, and a member of the governing council of the International AIDS Society.
From page 128...
... from the First Medical University of St. Petersburg, Russia, and holds an MMed in medical microbiology from the Nelson Mandela School of Medicine of the University of KwaZulu-Natal in South Africa.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.